Our interdisciplinary “Tox-Board” meets once a month. In an interdisciplinary panel of neurologists, cardiologists, rheumatologists, gastroenterologists, endocrinologists, hematooncologists and dermatologists we discuss complex, severe, rare and therapy- refractory immune-related side effects of immunotherapy (irAE).
Subsequently we give recommendations to the treating physician. Within this panel we also establish internal guidelines to improve side effect management and initiate scientific projects to further investigate pathogenetic mechanisms of irAE.
Monitoring of immunotherapy